Conferencia

Conferencia Prof Christopher Abell: Microdroplets and microencapsulation

26-10-2015

Aula de Seminarios do CIQUS

12:15 h

Ver PDF con cartel anunciador


The talk will describe the microfluidics microdroplets platform we have developed at Cambridge.

It will include:

  • An introduction to microdroplets.
  • Example applications in enyzmology and molecular biology.
  • Developing a mass spectrometric interface.
  • Using droplets for single cell analysis.
  • The development of a novel encapsulation technology.
  • Developing capsules-in-capsules

 

 

 

 

About Professor Abell

Chris Abell is the Professor of Biological Chemistry at the University of Cambridge. He leads a large multidisciplinary group interested in biological chemistry. His research is focused on using fragment-based methods in drug discovery and chemical biology. In 1999, he co-founded Astex, the world-leading company in fragment-based drug discovery. Chris also has research interests in developing microdroplets as a novel experimental platform (spin outs: Sphere Fluidics (2010) and Aqdot (2013)). Chris has published over 265 papers and is an inventor on numerous patents. He was a founding director of Cambridge Enterprise.